Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss

PHASE3CompletedINTERVENTIONAL
Enrollment

1,169

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

December 27, 2022

Study Completion Date

June 8, 2023

Conditions
Cognition Disorders
Interventions
DRUG

Placebo

Administered IV

DRUG

Solanezumab

Administered IV

Trial Locations (68)

3010

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Parkville

10016

New York University Medical Center, New York

10021

Weill Cornell Medical College, New York

10029

Mount Sinai School of Medicine, New York

10032

Columbia University Medical Center, New York

14226

Dent Neurological Institute, Amherst

14620

University of Rochester, Rochester

15213

University of Pittsburgh Medical Center, Pittsburgh

19102

Drexel University College of Medicine at EPPI, Philadelphia

19104

University of Pennsylvania Hospital, Philadelphia

20057

Georgetown University Hospital, Washington D.C.

20060

Howard University Hospital, Washington D.C.

21093

Johns Hopkins University School of Medicine, Baltimore

27157

Wake Forest University School of Medicine, Winston-Salem

29401

Roper Hospital, Charleston

30322

Emory University, Atlanta

32162

Compass Research -The Villages, The Villages

32224

Mayo Clinic-Jacksonville, Jacksonville

32806

Compass Research - Orlando, Orlando

33140

Wien Center for Clinical Research, Miami Beach

33407

Premiere Research Institute at Palm Beach Neurology, West Palm Beach

33445

Brain Matters Research, Delray Beach

33613

University of South Florida, Tampa

35294

University of Alabama at Birmingham, Birmingham

40504

University of Kentucky, Lexington

44122

Case Western Reserve University, Beachwood

46202

Indiana University School of Medicine, Indianapolis

48105

University of Michigan, Ann Arbor

52242

University of Iowa, Iowa City

53705

University of Wisconsin-Madison Hospital and Health Clinic, Madison

55905

Mayo Clinic, Rochester

60611

Northwestern University, Chicago

60612

Rush Alzheimer's Disease Center, Chicago

60640

Great Lakes Clinical Trials, Chicago

63110

Washington University School of Medicine, St Louis

66205

University of Kansas Hospital, Fairway

68198

Univ of Nebraska Med Center, Omaha

74104

Tulsa Clinical Research LLC, Tulsa

75235

University of Texas Southwestern Medical Center at Dallas, Dallas

77030

Baylor College of Medicine, Houston

Houston Methodist, Houston

85006

Banner Health Research Institute, Phoenix

85013

Barrow Neurological Institute, Phoenix

85351

Banner Sun Health Research Institute, Sun City

89106

Cleveland Clinic of Las Vegas, Las Vegas

90033

University of Southern California School of Medicine, Los Angeles

90095

University of California - Los Angeles, Los Angeles

92037

University of California - San Diego, La Jolla

92697

Institute for Memory Impairment & Neurological Disorders, Irvine

92705

Syrentis Clinical Research, Santa Ana

92868

Univ of California Irvine College of Medicine, Orange

94158

Univ of California San Francisco, San Francisco

94304

Veterans Affairs Medical Center Palo Alto, Palo Alto

94598

University of California, Davis - Health Systems, Walnut Creek

95816

Sutter Medical Group, Sacramento

97239

Oregon Health and Science University, Portland

98108

University of Washington School of Medicine, Seattle

06510

Yale University School of Medicine, New Haven

70808-4124

Pennington Biomedical Research Center, Baton Rouge

02115

Brigham and Womens Hospital, Boston

02118

Boston University Medical Center, Boston

02906

Butler Hospital, Providence

Rhode Island Hospital, Providence

N6C 0A7

For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician., London

M3B2S7

For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician., Toronto

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

V6T 2B5

For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician., Vancouver

113-8655

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Bunkyō City

All Listed Sponsors
collaborator

Alzheimer's Therapeutic Research Institute

OTHER

lead

Eli Lilly and Company

INDUSTRY